• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Study Type: Methodology

Heinemann Klaas, Imthurn Bruno, Marions Lena, Gerlinger Christoph, Becker Kerstin, Moehner Sabine, Faustmann Thomas, Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study Advances in Therapy. 2020; 2528-2537. 10.1007/s12325-020-01331-z.
Dinger Jürgen, M Kieble, Rare serious adverse events: comparison of patient- and physician-reported outcomes. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 732. DOI 10.1002.
Heinemann Klaas, Problems associated with comprehensive detection/validation of unexpected ADRs in a population. PRM Newsletter. 2010; Apr 2010;5:1-3,9-1.
Dinger Jürgen, Bardenheuer Kristina, Assmann Anita, International active surveillance study of women taking oral contraceptives (INAS-OC Study) BMC Medical Research Methodology. 2009; 9: 77.. 10.1186/1471-2288-9-77.
Behre H M, Heinemann Lothar A , Morales A, Pexman-Fieth C, Rationale, design and methods of the esprit study: energy, sexual desire and body proportions with AndroGel, Testosterone 1% gel therapy, in hypogonadal men. The Aging Male. 2008; 11:101-106.
Heinemann Lothar A , HPG – initiator & facilitator: the Menopause Rating Scale (MRS). HPG Schneider (Ed) Ein Vierteljahhundert Frauenheilkunde und Gebortshilfe aus Münsteraner Sicht. Hanser & Co GmbH, Münster. 2007; p. 198-203.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , Design issues in active surveillance studies: experience from the EURAS studies.. Pharmacoepidemiology and Drug Safety. 2007; 16: S253.
Heinemann Lothar A , Dinger Jürgen, The menopause rating scale (MRS) as outcome measure for hormone treatment. Pharmacoepidemiology and Drug Safety. 2006; 14: S44.
Heinemann Lothar A , Moore C, Dinger Jürgen, Stoehr D, Sensitivity as outcome measure of androgen replacement: the AMS scale. Health and Quality of Life Outcomes. 2006; 4:23.
Dinger Jürgen, Zimmermann T, Heinemann Lothar A , Stoehr D, Quality of life and hormone use: new validation results of MRS scale. Health and Quality of Life Outcomes. 2006; 4:32.
Dinger Jürgen, Heinemann Lothar A , European Active Surveillance Study of Women taking HRT (EURAS-HRT): study protocol BMC Women's Health. 2006; 6:1. DOI: 10.1186/1472-6874-6-1.
Heinemann Lothar A , Schneider HPG, Quality of life assessment in the menopause. Eskin B (Ed) The Menopause: Endocrinologic Basis & Management Options. 5th edition. Taylor & Francis Medical Books,London (Manuscript in print). 2005;
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.